Robbins Farley’s Sanofi SNY Stock Holding History

Robbins Farley’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-40	Closed	-$1.94K	–	213
2022 Q4	$1.94K	Buy	+40	New	+$1.76K	﹤0.01%	147

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Robbins Farley's SNY Position: Q1 2023 in Review

Robbins Farley sold out of Sanofi (SNY) in Q1 2023, closing a stake of 40 shares — an estimated $1.94K sold.

Robbins Farley first reported a position in SNY in Q4 2022 and held it in 1 quarter. The position peaked at $1.94K in Q4 2022. 678 funds tracked by Wall St. Rank hold SNY as of Q1 2023.

Robbins Farley reported no remaining Sanofi position as of Q1 2023 after selling out during the quarter.
Robbins Farley sold 40 Sanofi shares in Q1 2023, an estimated $1.94K.
Robbins Farley first reported a position in Sanofi in Q4 2022 and held it in 1 quarter.
Robbins Farley's Sanofi position peaked at $1.94K in Q4 2022.
678 funds tracked by Wall St. Rank held Sanofi as of Q1 2023.

Based on Robbins Farley's 13F filing for Q1 2023, filed 4 May 2023.